1. Home
  2. HITI vs MOLN Comparison

HITI vs MOLN Comparison

Compare HITI & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HITI
  • MOLN
  • Stock Information
  • Founded
  • HITI 2009
  • MOLN 2004
  • Country
  • HITI Canada
  • MOLN Switzerland
  • Employees
  • HITI N/A
  • MOLN N/A
  • Industry
  • HITI
  • MOLN
  • Sector
  • HITI
  • MOLN
  • Exchange
  • HITI Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • HITI 187.8M
  • MOLN 183.2M
  • IPO Year
  • HITI N/A
  • MOLN 2021
  • Fundamental
  • Price
  • HITI $2.30
  • MOLN $3.89
  • Analyst Decision
  • HITI Strong Buy
  • MOLN
  • Analyst Count
  • HITI 2
  • MOLN 0
  • Target Price
  • HITI $4.75
  • MOLN N/A
  • AVG Volume (30 Days)
  • HITI 283.6K
  • MOLN 2.4K
  • Earning Date
  • HITI 06-16-2025
  • MOLN 08-25-2025
  • Dividend Yield
  • HITI N/A
  • MOLN N/A
  • EPS Growth
  • HITI N/A
  • MOLN N/A
  • EPS
  • HITI N/A
  • MOLN N/A
  • Revenue
  • HITI $398,202,371.00
  • MOLN $2,525,030.00
  • Revenue This Year
  • HITI $12.43
  • MOLN N/A
  • Revenue Next Year
  • HITI $11.39
  • MOLN $866.67
  • P/E Ratio
  • HITI N/A
  • MOLN N/A
  • Revenue Growth
  • HITI 9.22
  • MOLN N/A
  • 52 Week Low
  • HITI $1.57
  • MOLN $3.36
  • 52 Week High
  • HITI $3.62
  • MOLN $12.22
  • Technical
  • Relative Strength Index (RSI)
  • HITI 53.11
  • MOLN 43.53
  • Support Level
  • HITI $2.14
  • MOLN $3.50
  • Resistance Level
  • HITI $2.35
  • MOLN $3.90
  • Average True Range (ATR)
  • HITI 0.08
  • MOLN 0.17
  • MACD
  • HITI -0.01
  • MOLN -0.01
  • Stochastic Oscillator
  • HITI 68.97
  • MOLN 12.70

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: